You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5 Results
Drug
Other Name(s): Lupron® (AbbVie) , Lupron Depot® (AbbVie) , Eligard® (Sanofi Aventis)
Aug 2016
Drug
Other Name(s): Lorbrena®
Feb 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Funding:
Exceptional Access Program
    lorlatinib - For the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer.
Feb 2025